Drug intelligence / Profile preview

Chufeng Yisun Tang

Development stage: Preclinical
Administration: Oral

Overview

Chufeng Yisun Tang (除风益损汤) is a classical Traditional Chinese Medicine (TCM) formula composed of several herbal ingredients, including Prepared Rehmannia Root (熟地黄), Angelica Sinensis (当归), White Peony Root (白芍), Ligusticum Chuanxiong (川芎), Ligusticum sinense (藁本), Peucedanum praeruptorum (前胡), and Saposhnikovia divaricata (防风). Traditionally, it is used to nourish blood, dispel wind, activate blood, and unblock collaterals, primarily indicated for eye injuries caused by foreign objects and headaches due to blood deficiency. Recent research has explored its potential in treating dry eye syndrome.

Other names: 除风益损汤

Targets

IL1B (Interleukin-1 beta)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on Chufeng Yisun Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chufeng Yisun Tang.

Explore the full profile